Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Does not alter device or atherosclerosis management; leaves open targeted platelet studies for thromboembolic prevention.
Reinthaler et al. (2016) studied this question.